Fachbereich Chemie
Publikationen von Anke Heisig
.
| Suche: FB Chemie / Hamburg | |
| 2020 | |
| 14 |
Bacterial Resistance to Antibiotics Anke Heisig, Peter Heisig -/- Herausgeber: Stefan Offermanns, Walter Rosenthal Encyclopedia of Molecular Pharmacology Online: 01 June 2020 (17 pp) (2020) |
2018 | |
| 13 |
Next-Generation Sequencing (NGS) - neue Nachweismethoden für Antibiotika-Resistenzgene Anke Heisig Update Antibiotikaresistenz: Entstehung, Epidemiologie, Wirkstoffentwicklung 50-63 (2018), ISBN 978-3-7692-7113-3 , Verlag: Deutscher Apotheker Verlag |
2016 | |
| 12 |
Detection of a Novel gyrB Mutation Associated with Fluoroquinolone-Nonsusceptible Salmonella enterica serovar Typhimurium Isolated from a Bloodstream Infection in Ghana Hassan M. Al-Emran, Anke Heisig, Denise Dekker, Yaw Adu-Sarkodie, Ligia Maria Cruz Espinoza, Ursula Panzner, Vera von Kalckreuth, Florian Marks, Se Eun Park, Nimako Sarpong, Jürgen May, Peter Heisig Clinical Infectious Diseases 62 (Suppl. 1) S47-S49 (2016) |
2014 | |
| 11 |
Uncomplicated Urinary Tract Infections and Antibiotic Resistance - Epidemiological and Mechanistic Aspects Bernd Wiedemann, Anke Heisig, Peter Heisig Antibiotics 3, 341-352 (2014) |
2013 | |
| 10 |
An improved assay for the detection of alterations in bacterial DNA supercoiling in vivo Mobarak Abu Mraheil, Anke Heisig, Peter Heisig Pharmazie 68, 541-548 (2013) |
2012 | |
| 9 |
Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia Joanne L. Platell, Darren J. Trott, James R. Johnson, Peter Heisig, Anke Heisig, Connie R. Clabots, Brian Johnston, Rowland N. Cobbold Antimicrobial Agents and Chemotherapy 56, 3898-3904 (2012) |
2011 | |
| 8 |
Commonality among Fluoroquinolone-Resistant Sequence Type ST131 Extraintestinal Escherichia coli Isolates from Humans and Companion Animals in Australia Joanne L. Platell, Rowland N. Cobbold, James R. Johnson, Anke Heisig, Peter Heisig, Connie Clabots, Michael A. Kuskowski, Darren J. Trott Antimicrobial Agents and Chemotherapy 55, 3782-3787 (2011) |
2010 | |
| 7 |
Skin bacteria after chlorhexidine exposure - is there a difference in response to human β-Defensin-3? Mirja Reichel, Anke Heisig, Peter Heisig, Günter Kampf European Journal of Clinical Microbiology & Infectious Diseases 29, 623-632 (2010) |
| 6 |
Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance Nadine-Christine Emrich, Anke Heisig, Will Stubbings, Harald Labischinski, Peter Heisig Journal of Antimicrobial Chemotherapy 65, 2530-2533 (2010) |
1993 | |
| 5 |
The antirepressor of phage P1. Isolation and interaction with the C1 repressor of P1 and P7 Hans-Dieter Riedel, Jochen Heinrich, Anke Heisig, Theodora Choli, Heinz Schuster FEBS Letters 334, 165-169 (1993) |
1989 | |
| 4 |
Organization of the immunity region immI of bacteriophage P1 and synthesis of the P1 antirepressor Anke Heisig, Hans-Dieter Riedel, Beate Dobrinski, Rudi Lurz, Heinz Schuster Journal of Molecular Biology 209, 525-538 (1989) |
| 3 |
Die Organisation der Immunitätsregion immI des Bakteriophagen P1 und die Synthese des P1 Antirepressors Anke Heisig (= Anke Jakschik) -/- Betreuer: Heinz Schuster Dissertation, Berlin (1989) |
1987 | |
| 2 |
The ban operon of bacteriophage P1. Localization of the promoter controlled by P1 repressor Rudi Lurz, Anke Heisig, Mathias Velleman, Beate Dobrinski, Heinz Schuster Journal of Biological Chemistry 262, 16575-16579 (1987) |
| 1 |
Regulation of the ban gene-containing operon of prophage P1 Anke Heisig, Iris Severin, Ann-Kristin Seefluth, Heinz Schuster Molecular and General Genetics 206, 368-376 (1987) |